517 related articles for article (PubMed ID: 28497941)
1. Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
De Vecchis R; Ariano C; Giasi A; Cioppa C
Minerva Cardioangiol; 2018 Jun; 66(3):349-359. PubMed ID: 28497941
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis.
Guerra F; Romandini A; Barbarossa A; Belardinelli L; Capucci A
Int J Cardiol; 2017 Jan; 227():284-291. PubMed ID: 27839812
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.
Fragakis N; Koskinas KC; Katritsis DG; Pagourelias ED; Zografos T; Geleris P
Am J Cardiol; 2012 Sep; 110(5):673-7. PubMed ID: 22621799
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy.
Tsanaxidis N; Aidonidis I; Hatziefthimiou A; Daskalopoulou SS; Giamouzis G; Triposkiadis F; Skoularigis I
Pacing Clin Electrophysiol; 2017 Apr; 40(4):372-378. PubMed ID: 28182279
[TBL] [Abstract][Full Text] [Related]
6. Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation.
White CM; Nguyen E
Ann Pharmacother; 2017 Mar; 51(3):245-252. PubMed ID: 27758968
[TBL] [Abstract][Full Text] [Related]
7. Role of ranolazine in the prevention and treatment of atrial fibrillation: A meta-analysis of randomized clinical trials.
Gong M; Zhang Z; Fragakis N; Korantzopoulos P; Letsas KP; Li G; Yan GX; Liu T
Heart Rhythm; 2017 Jan; 14(1):3-11. PubMed ID: 27746384
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine for the treatment of atrial fibrillation.
Rosa GM; Dorighi U; Ferrero S; Brunacci M; Bertero G; Brunelli C
Expert Opin Investig Drugs; 2015 Jun; 24(6):825-36. PubMed ID: 25872749
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery.
Simopoulos V; Tagarakis GI; Daskalopoulou SS; Daskalopoulos ME; Lenos A; Chryssagis K; Skoularingis I; Molyvdas PA; Tsilimingas NB; Aidonidis I
Angiology; 2014 Apr; 65(4):294-7. PubMed ID: 23427280
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
De Ferrari GM; Maier LS; Mont L; Schwartz PJ; Simonis G; Leschke M; Gronda E; Boriani G; Darius H; Guillamón Torán L; Savelieva I; Dusi V; Marchionni N; Quintana Rendón M; Schumacher K; Tonini G; Melani L; Giannelli S; Alberto Maggi C; Camm AJ;
Heart Rhythm; 2015 May; 12(5):872-8. PubMed ID: 25602175
[TBL] [Abstract][Full Text] [Related]
11. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.
Cybulski J; Kułakowski P; Budaj A; Danielewicz H; Maciejewicz J; Kawka-Urbanek T; Ceremuzyński L
Clin Cardiol; 2003 Jul; 26(7):329-35. PubMed ID: 12862299
[TBL] [Abstract][Full Text] [Related]
12. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
Hilleman DE; Spinler SA
Pharmacotherapy; 2002 Jan; 22(1):66-74. PubMed ID: 11794432
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients.
Simopoulos V; Hevas A; Hatziefthimiou A; Dipla K; Skoularigis I; Tsilimingas N; Aidonidis I
Cardiovasc Drugs Ther; 2018 Dec; 32(6):559-565. PubMed ID: 30255400
[TBL] [Abstract][Full Text] [Related]
14. Low-dose amiodarone for the prevention of atrial fibrillation after coronary artery bypass grafting in patients older than 70 years.
Gu S; Su PX; Liu Y; Yan J; Zhang XT; Wang TY
Chin Med J (Engl); 2009 Dec; 122(24):2928-32. PubMed ID: 20137476
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.
Miles RH; Passman R; Murdock DK
Am J Cardiol; 2011 Sep; 108(5):673-6. PubMed ID: 21726841
[TBL] [Abstract][Full Text] [Related]
17. Intravenous amiodarone for conversion of atrial fibrillation: misled by meta-analysis?
Slavik RS; Zed PJ
Pharmacotherapy; 2004 Jun; 24(6):792-8. PubMed ID: 15222670
[TBL] [Abstract][Full Text] [Related]
18. Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation.
Samuels LE; Holmes EC; Samuels FL
Ann Thorac Surg; 2005 Jan; 79(1):113-6. PubMed ID: 15620926
[TBL] [Abstract][Full Text] [Related]
19. Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation.
Orso D; Santangelo S; Guglielmo N; Bove T; Cilenti F; Cristiani L; Copetti R
Am J Cardiovasc Drugs; 2023 Jul; 23(4):355-377. PubMed ID: 37233967
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis.
deSouza IS; Tadrous M; Sexton T; Benabbas R; Carmelli G; Sinert R
Europace; 2020 Jun; 22(6):854-869. PubMed ID: 32176779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
